NEW YORK (Reuters Health) – Brachytherapy is a viable option for prostate cancer patients 60 and younger, the authors of a new report in BJUI conclude. “Prostate cancer…
NEW YORK (Reuters Health) – Urologists from China report that the alpha-adrenergic receptor antagonist tamsulosin is a good first-line drug for outpatient medical expulsive therapy (MET) in patients…
NEW YORK (Reuters Health) – The tumor volume threshold of 0.5 mL for clinically insignificant prostate cancer, established in the early 1990s, remains valid, according to researchers who…
NEW YORK (Reuters Health) – A newer ureteral stent, designed to be more comfortable than an older stent, actually isn’t, according to results of a randomized controlled trial.…
NEW YORK (Reuters Health) – There appear to be several problems with the current clinical staging criteria for localized prostate cancer, according to a study published online today…
NEW YORK (Reuters Health) – Despite declining use, perineal radical prostatectomy (PRP) yields outcomes that are equal to, or better than, those of retropubic radical prostatectomy (RRP) and…
NEW YORK (Reuters Health) – In older men with benign prostatic hyperplasia (BPH) bothered by nocturnal polyuria, a low dose of desmopressin at bedtime can help, according to…
NEW YORK (Reuters Health) – Outcomes of cryoablation of small renal masses are similar whether the procedure is performed surgically or percutaneously, according the results of a meta-analysis…
NEW YORK (Reuters Health) – It’s reasonable to insert a suprapubic catheter using a closed technique when the distended bladder is readily palpable; however, when the bladder cannot…
NEW YORK (Reuters Health) – About one in seven children with a first urinary tract infection have evidence of renal scarring subsequently, a meta-analysis of published studies shows.…